If you liked this article you might like

Exact Sciences' Estimates Raised on Increased Contracts With Healthcare Providers
Exact Sciences Stock Falls on Secondary Stock Sale
Biotech Movers: Shire Falls on Stem Cell Program Transfer; Calithera, Synergy Up on FDA Approvals
Exact Sciences: Cramer's Top Takeaways